Skip to main content

Table 1 Clinical, anamnestic characteristics and laboratory blood test results of patients

From: Relationships between indicators of prothrombotic activity and coronary microvascular dysfunction in patients with myocardial infarction with obstructive and non-obstructive coronary artery disease

Number of patients, n%

MINOCA, n = 16

MICAD, n = 21

p-value

Men, n (%)

7 (43.7)

17 (80.9)

0.02

Age, Me (Q25; Q75)

66.0 (54.71)

60 (56;68)

0.33

Hypertension, n (%)

13 (81.3)

16 (76.1)

0.71

Dyslipidemia, n (%)

14 (87.5)

17 (80.9)

0.89

Overweight, n (%)

4 (25)

11 (52.3)

0.15

Family history of CAD, n (%)*

7 (43.7)

13 (61.9)

0.27

Smoking, n (%)

5 (31.3)

11 (52.3)

0.26

Diabetes mellitus, n (%)

0

4 (19.0)

0.02

GFR, ml / min / 1.73 m2, Me (Q25; Q75)

71.5 (54.0;80.0)

79.0 (65.0;89.0)

0.20

History of angina pectoris, n (%)

10 (62.5)

6 (28.5)

0.04

A history of stroke, n (%)

1 (5.2)

2 (9.5)

0.71

Peripheral atherosclerosis, n (%)

4 (25)

7 (33.3)

0.58

Time of admission to the hospital, min, Me (Q25; Q75)

390 (146.5;870)

180 (98;240)

0.02

STEMI, n (%)

10 (62.5)

19 (90.4)

0.01

GRACE, risk, Me (Q25; Q75)

2.0 (2.0;3.5)

2.3 (2.0;5.0)

0.26

Thrombolytic therapy, n (%)

3 (18.7)

11 (52.3)

0.007

TIMI 2 flow, n (%)

9 (56.3)

1(4.7)

0.01

Wall motion score index, score

1.0 (1.0;1.2)

1.2 (1.2;1.5)

0.04

Left ventricular ejection fraction, %

60.0 (45.0;60.0)

56.0 (50.0;60.0)

0.51

Acute apical left ventricle aneurysm with parietal thrombosis, n (%)

3 (18.7)

0

0.03

Acute apical left ventricle aneurysm, n (%)

0

2 (9.5)

0.62

Troponin I, ng/ml, 2 day

0.5 (0.11;8.3)

4.9 (1.0;25.2)

0.02

Troponin I, ng/ml, 4 day

0.4 (0.07;1.7)

0.7 (0.5;4.4)

0.04

Troponin I, ng/ml, 7 day

0.08 (0.02;0.2)

0.4 (0.2;0.9)

 < 0.001

  1. *Burdened heredity for cardiovascular pathology
  2. GFR glomerular filtration rate; STEMI ST-segment elevation myocardial infarction